Novo Nordis Short

Shorting Novo Nordisk may be considered due to potential overvaluation, rising competition in diabetes and obesity markets, supply chain challenges, and risks from patent expirations. Regulatory hurdles, slower demand in key regions, and macroeconomic factors like healthcare budgets and inflation could further impact growth. However, thorough analysis is essential, as shorting carries high risk.

Nota

at the neckline, could have a bit of oscillation, but once break down $120, heading to the target $100.

Nota

Neckline broke, any small fundamental issue would incur the acceleration to the target

Nota

will close half of my put position when it hits below $110 prior to the earning, that would give the trade a 75% profit

Trade fechado: objetivo atingido

Closed my position.

AZ_Cap

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.